Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor plus aspirin after stent-assisted coiling for intracranial aneurysms
ChiCTR2600131491Phase 4Recruiting
- Sponsor
- Zhuhai People's Hospital
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor, aspirin and clopidogrel in brain aneurysm (IA) (2 arms), sponsored by Zhuhai People's Hospital. Primary endpoints: Bleeding outcome and Thromboembolic events. Started Aug 2026; status: recruiting.
02
Drugs
ticagreloraspirinclopidogrel
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on ChiCTR2600131491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131491.